Inventor · disambiguated record
David Fitzgerald
Also filed as: FITZGERALD DAVID · FITZGERALD DAVID J
33 granted patents·7 pending applications·2,084 citations·filing 1984–2018
98Inventor score
Top patents by PatentIndex Score
40 records- 0197US5602095ARecombinant pseudomonas exotoxin with increased activityUS ARMY·Filed 1995·Granted Feb 11, 1997·200 cites·13 claims
- 0297US4892827ARecombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effectsUS HEALTH·Filed 1986·Granted Jan 9, 1990·180 cites·10 claims
- 0397US4545985APseudomonas exotoxin conjugate immunotoxinsUS HEALTH·Filed 1984·Granted Oct 8, 1985·160 cites·16 claims
- 0495US5854044ARecombinant pseudomonas exotoxin with increased activityNAT INST HEALTH·Filed 1995·Granted Dec 29, 1998·135 cites·13 claims
- 0595US5512658APseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acidsUS HEALTH·Filed 1993·Granted Apr 30, 1996·149 cites·9 claims
- 0694US5608039ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1994·Granted Mar 4, 1997·163 cites·18 claims
- 0792US6423513B1Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteinsUS HEALTH·Filed 2000·Granted Jul 23, 2002·30 cites·5 claims
- 0892US5696237ARecombinant antibody-toxin fusion proteinUS HEALTH·Filed 1995·Granted Dec 9, 1997·91 cites·5 claims
- 0991US5821238ARecombinant pseudomonas exotoxin with increased activityUS ARMY·Filed 1995·Granted Oct 13, 1998·104 cites·6 claims
- 1090US8871906B2Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopesPASTAN IRA H·Filed 2008·Granted Oct 28, 2014·27 cites·41 claims
- 1190US7541034B1Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumorsUS HEALTH·Filed 1998·Granted Jun 2, 2009·93 cites·1 claims
- 1288US5458878AP. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicityUS HEALTH·Filed 1990·Granted Oct 17, 1995·60 cites·29 claims
- 1387US8092809B2Pseudomonas exotoxin A-like chimeric immunogensFITZGERALD DAVID·Filed 2007·Granted Jan 10, 2012·12 cites·16 claims
- 1486US9592304B2Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumorsFITZGERALD DAVID J·Filed 2009·Granted Mar 14, 2017·7 cites·1 claims
- 1586US5328984ARecombinant chimeric proteins deliverable across cellular membranes into cytosol of target cellsUS AS REPRESENTED BY THE DEPAR·Filed 1991·Granted Jul 12, 1994·87 cites·13 claims
- 1685US5863745ARecombinant antibody-toxin fusion proteinUS HEALTH·Filed 1995·Granted Jan 26, 1999·65 cites·3 claims
- 1784US6099842ARecombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxinUS HEALTH·Filed 1990·Granted Aug 8, 2000·72 cites·4 claims
- 1883US6881718B1Disulfide conjugated cell toxins and methods of making and using themUS HEALTH·Filed 2000·Granted Apr 19, 2005·10 cites·19 claims
- 1983US6051405AConstructs encoding recombinant antibody-toxin fusion proteinsUS HEALTH·Filed 1992·Granted Apr 18, 2000·56 cites·9 claims
- 2083US5705163ATarget-specific, cytotoxic, recombinant pseudomonas exotoxinUS HEALTH·Filed 1995·Granted Jan 6, 1998·49 cites·21 claims
- 2182US8907060B2Mutated Pseudomonas exotoxins with reduced antigenicityPASTAN IRA H·Filed 2006·Granted Dec 9, 2014·6 cites·105 claims
- 2280US5082927ASelectively cytotoxic IL-4-PE40 fusion proteinUS HEALTH·Filed 1989·Granted Jan 21, 1992·58 cites·4 claims
- 2380US4958009AAnti-human ovarian cancer immunotoxins and methods of use thereofCETUS CORP·Filed 1987·Granted Sep 18, 1990·46 cites·19 claims
- 2478US5206353ACD-4/cytotoxic gene fusionsUS COMMERCE·Filed 1988·Granted Apr 27, 1993·26 cites·9 claims
- 2577US7314632B1Pseudomonas exotoxin A-like chimeric immunogensUS HEALTH·Filed 1998·Granted Jan 1, 2008·39 cites·12 claims
- 2677US7314625B2Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequencesUS HEALTH·Filed 2001·Granted Jan 1, 2008·8 cites·13 claims
- 2776US5587455ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1994·Granted Dec 24, 1996·28 cites·8 claims
- 2875US7824695B1Delivery of proteins across polar epithelial cell layersUS HEALTH·Filed 2000·Granted Nov 2, 2010·10 cites·30 claims
- 2974US5990296ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1996·Granted Nov 23, 1999·37 cites·2 claims
- 3072US6426075B1Protease-activatable pseudomonas exotoxin A-like proproteinsUS HEALTH·Filed 1997·Granted Jul 30, 2002·33 cites·19 claims
- 3169US5705156APsuedomonas exotoxins of low animal toxicity and high cytocidal activityUS HEALTH·Filed 1995·Granted Jan 6, 1998·24 cites·13 claims
- 3264US2009081235A1Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune responseUS GOV HEALTH & HUMAN SERV·Filed 2008·Application pending·0 cites
- 3363US2011250199A1Immunotoxins and uses thereofGOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT·Filed 2009·Application pending·0 cites
- 3462US2005079171A1Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune responseUS GOV HEALTH & HUMAN SERV·Filed 2003·Application pending·0 cites
- 3553US5428143ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1993·Granted Jun 27, 1995·9 cites·1 claims
- 3652US2007003578A1Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequencesUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 3746US2020010850A1Efficient cell free production of papillomavirus gene transfer vectorsTHE USA AS REPRESEENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Application pending·0 cites
- 3845US4806494AMonoclonal antibody against ovarian cancer cells (OVB-3)US DEPARTMENT OF HEALTH & HUMA·Filed 1986·Granted Feb 21, 1989·10 cites·5 claims
- 3936US2012276190A1Therapy with a chimeric molecule and a pro-apoptotic agentFITZGERALD DAVID J·Filed 2012·Application pending·0 cites
- 4033US2003054012A1Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune responseFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Fitzgerald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →